These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 21861185)

  • 1. Nod2: a key regulator linking microbiota to intestinal mucosal immunity.
    Biswas A; Petnicki-Ocwieja T; Kobayashi KS
    J Mol Med (Berl); 2012 Jan; 90(1):15-24. PubMed ID: 21861185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nod2: A Critical Regulator of Ileal Microbiota and Crohn's Disease.
    Sidiq T; Yoshihama S; Downs I; Kobayashi KS
    Front Immunol; 2016; 7():367. PubMed ID: 27703457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nod2 is essential for temporal development of intestinal microbial communities.
    Rehman A; Sina C; Gavrilova O; Häsler R; Ott S; Baines JF; Schreiber S; Rosenstiel P
    Gut; 2011 Oct; 60(10):1354-62. PubMed ID: 21421666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From sensing to shaping microbiota: insights into the role of NOD2 in intestinal homeostasis and progression of Crohn's disease.
    Balasubramanian I; Gao N
    Am J Physiol Gastrointest Liver Physiol; 2017 Jul; 313(1):G7-G13. PubMed ID: 28450278
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of NOD2 on the microbiota in Crohn's disease.
    Lauro ML; Burch JM; Grimes CL
    Curr Opin Biotechnol; 2016 Aug; 40():97-102. PubMed ID: 27035071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
    Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
    Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nod2 is required for the regulation of commensal microbiota in the intestine.
    Petnicki-Ocwieja T; Hrncir T; Liu YJ; Biswas A; Hudcovic T; Tlaskalova-Hogenova H; Kobayashi KS
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15813-8. PubMed ID: 19805227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.
    Wehkamp J; Harder J; Weichenthal M; Schwab M; Schäffeler E; Schlee M; Herrlinger KR; Stallmach A; Noack F; Fritz P; Schröder JM; Bevins CL; Fellermann K; Stange EF
    Gut; 2004 Nov; 53(11):1658-64. PubMed ID: 15479689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOD2 Influences Trajectories of Intestinal Microbiota Recovery After Antibiotic Perturbation.
    Moltzau Anderson J; Lipinski S; Sommer F; Pan WH; Boulard O; Rehman A; Falk-Paulsen M; Stengel ST; Aden K; Häsler R; Bharti R; Künzel S; Baines JF; Chamaillard M; Rosenstiel P
    Cell Mol Gastroenterol Hepatol; 2020; 10(2):365-389. PubMed ID: 32289499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of human enteric α-defensins by NOD2 in the Paneth cell lineage.
    Tan G; Zeng B; Zhi FC
    Eur J Cell Biol; 2015 Jan; 94(1):60-6. PubMed ID: 25433720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cytosolic Microbial Receptor Nod2 Regulates Small Intestinal Crypt Damage and Epithelial Regeneration following T Cell-Induced Enteropathy.
    Zanello G; Goethel A; Rouquier S; Prescott D; Robertson SJ; Maisonneuve C; Streutker C; Philpott DJ; Croitoru K
    J Immunol; 2016 Jul; 197(1):345-55. PubMed ID: 27206769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of human enteric antimicrobial peptides by NOD2 during differentiation of the paneth cell lineage.
    Tan G; Li RH; Li C; Wu F; Zhao XM; Ma JY; Lei S; Zhang WD; Zhi FC
    Sci Rep; 2015 Feb; 5():8383. PubMed ID: 25670499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of intestinal microbiota by the NLR protein family.
    Biswas A; Kobayashi KS
    Int Immunol; 2013 Apr; 25(4):207-14. PubMed ID: 23325116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human defensins in Crohn's disease.
    Wehkamp J; Fellermann K; Stange EF
    Chem Immunol Allergy; 2005; 86():42-54. PubMed ID: 15976487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOD2 mutation and mice: no Crohn's disease but many lessons to learn.
    Wehkamp J; Stange EF
    Trends Mol Med; 2005 Jul; 11(7):307-9. PubMed ID: 15955743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacterial recognition of the intestinal microbial flora: an important risk factor for Crohn's disease].
    Villani AC; Franchimont D
    Med Sci (Paris); 2010 Jan; 26(1):36-7. PubMed ID: 20132772
    [No Abstract]   [Full Text] [Related]  

  • 18. Insights into the molecular basis of the NOD2 signalling pathway.
    Boyle JP; Parkhouse R; Monie TP
    Open Biol; 2014 Dec; 4(12):. PubMed ID: 25520185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense.
    Wehkamp J; Stange EF
    Ann N Y Acad Sci; 2006 Aug; 1072():321-31. PubMed ID: 17057212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
    van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ
    Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.